SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation

Recent data suggest that SRC family kinases (SFKs) could represent potential therapeutic targets for rhabdomyosarcoma (RMS), the most common soft-tissue sarcoma in children. Here, we assessed the effect of a recently developed selective SFK inhibitor (a pyrazolo[3,4-d]pyrimidine derivative, called S...

Descripción completa

Detalles Bibliográficos
Autores principales: Casini, Nadia, Forte, Iris Maria, Mastrogiovanni, Gianmarco, Pentimalli, Francesca, Angelucci, Adriano, Festuccia, Claudio, Tomei, Valentina, Ceccherini, Elisa, Di Marzo, Domenico, Schenone, Silvia, Botta, Maurizio, Giordano, Antonio, Indovina, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494948/
https://www.ncbi.nlm.nih.gov/pubmed/25762618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494948/
https://www.ncbi.nlm.nih.gov/pubmed/25762618

Ejemplares similares